Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Other Operating Assets
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Other Operating Assets of $1.47 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-12
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2023-03-31 was $27.09K, a 6.23% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was -$1.66M, a 3678.88% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $28.89K.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2022-06-30 was $28.89K.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for fiscal 2023 was $1.47M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$1.57M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for fiscal 2021 was -$187.65K, a 225.88% decline from fiscal 2020.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating assets for fiscal 2020 was $149.07K, a 262.30% increase from fiscal 2019.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $1.47M 10-K · filed 2024-03-12 | ||||||
| 2023-03-31 | $27.09K 10-Q · filed 2023-05-09 | -$1.63M derived: sum of 2 quarters · filed 2024-03-12 | -$1.60M derived: sum of 3 quarters · filed 2024-03-12 | -$1.58M derived: sum of 4 quarters · filed 2024-03-12 | |||
| 2022-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$1.63M derived: sum of 2 quarters · filed 2024-03-12 | -$1.60M derived: sum of 3 quarters · filed 2024-03-12 | -$1.57M 10-K · filed 2024-03-12 | $108.96K 10-K · filed 2023-03-07 | ||
| 2022-09-30 | $28.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $57.78K derived: sum of 2 quarters · filed 2022-11-08 | $86.67K 10-Q · filed 2022-11-08 | $133.06K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2022-06-30 | $28.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $57.78K 10-Q · filed 2022-08-09 | $104.17K derived: sum of 3 quarters · filed 2023-05-09 | $101.55K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2022-03-31 | $28.89K 10-Q · filed 2023-05-09 | $75.28K derived: sum of 2 quarters · filed 2023-05-09 | $72.66K derived: sum of 3 quarters · filed 2023-05-09 | -$228.76K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $46.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $43.77K derived: sum of 2 quarters · filed 2023-03-07 | -$257.65K derived: sum of 3 quarters · filed 2023-03-07 | -$187.65K 10-K · filed 2023-03-07 | |||
| 2021-09-30 | -$2.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$304.04K derived: sum of 2 quarters · filed 2022-11-08 | -$234.04K 10-Q · filed 2022-11-08 | -$13.04K derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | -$301.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$231.42K 10-Q · filed 2022-08-09 | -$10.43K derived: sum of 3 quarters · filed 2022-08-09 | -$11.47K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $70.00K 10-Q · filed 2022-05-10 | $291.00K derived: sum of 2 quarters · filed 2022-05-10 | $289.95K derived: sum of 3 quarters · filed 2022-05-10 | $289.95K derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $219.95K derived: sum of 2 quarters · filed 2022-03-08 | $219.95K derived: sum of 3 quarters · filed 2022-03-08 | $149.07K 10-K · filed 2022-03-08 | |||
| 2020-09-30 | -$1.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.04K derived: sum of 2 quarters · filed 2021-11-12 | -$71.93K 10-Q · filed 2021-11-12 | -$120.99K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$70.88K 10-Q · filed 2021-08-12 | $70.88K 10-Q · filed 2020-08-06 | -$119.95K derived: sum of 3 quarters · filed 2021-08-12 | -$109.14K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$70.88K 10-Q · filed 2021-05-13 | -$119.95K derived: sum of 2 quarters · filed 2021-05-13 | -$109.14K derived: sum of 3 quarters · filed 2021-05-13 | -$21.50K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$49.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$38.26K derived: sum of 2 quarters · filed 2021-03-15 | $49.38K derived: sum of 3 quarters · filed 2021-03-15 | $41.15K 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $10.81K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | $98.45K derived: sum of 2 quarters · filed 2020-11-09 | $90.21K 10-Q · filed 2020-11-09 | $114.09K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $87.64K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $79.40K 10-Q/A · filed 2020-08-31 | $103.29K derived: sum of 3 quarters · filed 2020-08-31 | $58.80K derived: sum of 4 quarters · filed 2020-08-31 | |||
| 2019-03-31 | -$8.23K 10-Q · filed 2020-05-11 | $8.23K 10-Q · filed 2019-05-09 | $15.65K derived: sum of 2 quarters · filed 2020-05-11 | -$28.84K derived: sum of 3 quarters · filed 2020-05-11 | $13.68K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $23.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$20.60K derived: sum of 2 quarters · filed 2020-03-16 | $21.91K derived: sum of 3 quarters · filed 2020-03-16 | $3.05K 10-K · filed 2020-03-16 | |||
| 2018-09-30 | -$44.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.97K derived: sum of 2 quarters · filed 2019-11-07 | -$20.84K 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $42.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $23.65K 10-Q · filed 2019-08-08 | |||||
| 2018-03-31 | -$18.86K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |